|   | 
|   | 
|   | 
| 
 
			 | 
AN ACT
 | 
| 
 
			 | 
relating to the Cancer Prevention and Research Institute of Texas. | 
| 
 
			 | 
       BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | 
| 
 
			 | 
       SECTION 1.  Section 102.001(3), Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
             (3)  "Research and prevention programs committee"  | 
| 
 
			 | 
means the Cancer Prevention and Research Institute of Texas  | 
| 
 
			 | 
Scientific Research and Prevention Programs committees appointed  | 
| 
 
			 | 
by the executive director [Committee]. | 
| 
 
			 | 
       SECTION 2.  Subchapter B, Chapter 102, Health and Safety  | 
| 
 
			 | 
Code, is amended by adding Section 102.056 to read as follows: | 
| 
 
			 | 
       Sec. 102.056.  SALARY.  The institute may supplement the  | 
| 
 
			 | 
salary of the executive director and other senior institute staff  | 
| 
 
			 | 
members.  Funding for a salary supplement may come from gifts,  | 
| 
 
			 | 
grants, donations, or appropriations. | 
| 
 
			 | 
       SECTION 3.  Section 102.103(a), Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       (a)  Oversight committee members appointed by the governor,  | 
| 
 
			 | 
lieutenant governor, and speaker of the house serve staggered  | 
| 
 
			 | 
six-year [four-year] terms, with the terms of three members  | 
| 
 
			 | 
expiring on January 31 of each odd-numbered year. | 
| 
 
			 | 
       SECTION 4.  Subchapter C, Chapter 102, Health and Safety  | 
| 
 
			 | 
Code, is amended by adding Section 102.108 to read as follows: | 
| 
 
			 | 
       Sec. 102.108.  RULEMAKING AUTHORITY.  The oversight  | 
| 
 
			 | 
committee may adopt rules to administer this chapter. | 
| 
 
			 | 
       SECTION 5.  Section 102.151, Health and Safety Code, is  | 
| 
 
			 | 
amended by adding Subsections (a-1) and (d) to read as follows: | 
| 
 
			 | 
       (a-1)  The executive director, with approval by simple  | 
| 
 
			 | 
majority of the members of the oversight committee, shall appoint  | 
| 
 
			 | 
as members of scientific research and prevention programs  | 
| 
 
			 | 
committees experts in the field of cancer research and prevention. | 
| 
 
			 | 
       (d)  A member of a scientific research and prevention  | 
| 
 
			 | 
programs committee may receive an honorarium.  Subchapter B,  | 
| 
 
			 | 
Chapter 2254, Government Code, does not apply to an honorarium made  | 
| 
 
			 | 
to a committee member under this chapter. | 
| 
 
			 | 
       SECTION 6.  Section 102.152, Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       Sec. 102.152.  TERMS OF RESEARCH AND PREVENTION PROGRAMS  | 
| 
 
			 | 
COMMITTEE MEMBERS.  Members of a [the] research and prevention  | 
| 
 
			 | 
programs committee serve for [four-year] terms as determined by the  | 
| 
 
			 | 
executive director. | 
| 
 
			 | 
       SECTION 7.  The heading to Subchapter D, Chapter 102, Health  | 
| 
 
			 | 
and Safety Code, is amended to read as follows: | 
| 
 
			 | 
SUBCHAPTER D.  COMMITTEES [RESEARCH AND PREVENTION PROGRAMS 
 | 
| 
 
			 | 
COMMITTEE] | 
| 
 
			 | 
       SECTION 8.  Section 102.153, Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       Sec. 102.153.  EXPENSES.  Members of the university advisory  | 
| 
 
			 | 
committee or any ad hoc advisory committee appointed under this  | 
| 
 
			 | 
subchapter [the research and prevention programs committee] serve  | 
| 
 
			 | 
without compensation but are entitled to reimbursement for actual  | 
| 
 
			 | 
and necessary expenses in attending meetings of the committee or  | 
| 
 
			 | 
performing other official duties authorized by the presiding  | 
| 
 
			 | 
officer. | 
| 
 
			 | 
       SECTION 9.  Subchapter D, Chapter 102, Health and Safety  | 
| 
 
			 | 
Code, is amended by adding Sections 102.154, 102.155, and 102.156  | 
| 
 
			 | 
to read as follows: | 
| 
 
			 | 
       Sec. 102.154.  UNIVERSITY ADVISORY COMMITTEE.  (a)  The  | 
| 
 
			 | 
Cancer Prevention and Research Institute of Texas University  | 
| 
 
			 | 
Advisory Committee is composed of the following members: | 
| 
 
			 | 
             (1)  two members appointed by the chancellor of The  | 
| 
 
			 | 
University of Texas System to represent: | 
| 
 
			 | 
                   (A)  The University of Texas Southwestern Medical  | 
| 
 
			 | 
Center at Dallas; | 
| 
 
			 | 
                   (B)  The University of Texas Medical Branch at  | 
| 
 
			 | 
Galveston; | 
| 
 
			 | 
                   (C)  The University of Texas Health Science Center  | 
| 
 
			 | 
at Houston; | 
| 
 
			 | 
                   (D)  The University of Texas Health Science Center  | 
| 
 
			 | 
at San Antonio; | 
| 
 
			 | 
                   (E)  The University of Texas Health Center at  | 
| 
 
			 | 
Tyler; or | 
| 
 
			 | 
                   (F)  The University of Texas M. D. Anderson Cancer  | 
| 
 
			 | 
Center; | 
| 
 
			 | 
             (2)  one member appointed by the chancellor of The  | 
| 
 
			 | 
Texas A&M University System to represent: | 
| 
 
			 | 
                   (A)  The Texas A&M University System Health  | 
| 
 
			 | 
Science Center; or | 
| 
 
			 | 
                   (B)  the teaching hospital for The Texas A&M  | 
| 
 
			 | 
Health Science Center College of Medicine; | 
| 
 
			 | 
             (3)  one member appointed by the chancellor of the  | 
| 
 
			 | 
Texas Tech University System to represent the Texas Tech University  | 
| 
 
			 | 
Health Sciences Center; | 
| 
 
			 | 
             (4)  one member appointed by the chancellor of the  | 
| 
 
			 | 
University of Houston System to represent the system; | 
| 
 
			 | 
             (5)  one member appointed by the chancellor of the  | 
| 
 
			 | 
Texas State University System to represent the system; | 
| 
 
			 | 
             (6)  one member appointed by the chancellor of the  | 
| 
 
			 | 
University of North Texas System to represent the system; | 
| 
 
			 | 
             (7)  one member appointed by the president of Baylor  | 
| 
 
			 | 
College of Medicine; | 
| 
 
			 | 
             (8)  one member appointed by the president of Rice  | 
| 
 
			 | 
University; and | 
| 
 
			 | 
             (9)  members appointed at the executive director's  | 
| 
 
			 | 
discretion by the chancellors of other institutions. | 
| 
 
			 | 
       (b)  The university advisory committee shall advise the  | 
| 
 
			 | 
oversight committee and a research and prevention programs  | 
| 
 
			 | 
committee regarding the role of institutions of higher education in  | 
| 
 
			 | 
cancer research. | 
| 
 
			 | 
       Sec. 102.155.  AD HOC ADVISORY COMMITTEE.  (a)  The oversight  | 
| 
 
			 | 
committee shall create an ad hoc committee of experts to address  | 
| 
 
			 | 
childhood cancers.  The oversight committee, as necessary, may  | 
| 
 
			 | 
create additional ad hoc committees of experts to advise the  | 
| 
 
			 | 
oversight committee on issues relating to cancer. | 
| 
 
			 | 
       (b)  Ad hoc committee members shall serve for a period  | 
| 
 
			 | 
determined by the oversight committee. | 
| 
 
			 | 
       Sec. 102.156.  CONFLICT OF INTEREST.  (a)  A member of a  | 
| 
 
			 | 
research and prevention programs committee, the university  | 
| 
 
			 | 
advisory committee, or any ad hoc committee appointed under this  | 
| 
 
			 | 
subchapter shall disclose in writing to the executive director if  | 
| 
 
			 | 
the member has an interest in a matter that comes before the  | 
| 
 
			 | 
member's committee or has a substantial financial interest in an  | 
| 
 
			 | 
entity that has a direct interest in the matter. | 
| 
 
			 | 
       (b)  The member shall recuse himself or herself from the  | 
| 
 
			 | 
committee's deliberations and actions on the matter in Subsection  | 
| 
 
			 | 
(a) and may not participate in the committee's decision on the  | 
| 
 
			 | 
matter. | 
| 
 
			 | 
       (c)  A person has a substantial financial interest in an  | 
| 
 
			 | 
entity if the person: | 
| 
 
			 | 
             (1)  is an employee, member, director, or officer of  | 
| 
 
			 | 
the entity; or | 
| 
 
			 | 
             (2)  owns or controls, directly or indirectly, more  | 
| 
 
			 | 
than a five percent interest in the entity. | 
| 
 
			 | 
       SECTION 10.  Sections 102.203(c) and (d), Health and Safety  | 
| 
 
			 | 
Code, are amended to read as follows: | 
| 
 
			 | 
       (c)  A person receiving money under this subchapter for  | 
| 
 
			 | 
cancer research may not spend more than five percent of the money  | 
| 
 
			 | 
for indirect costs. For purposes of this subsection, "indirect  | 
| 
 
			 | 
costs" means the expenses of doing business that are not readily  | 
| 
 
			 | 
identified with a particular grant, contract, project, function, or  | 
| 
 
			 | 
activity, but are necessary for the general operation of the  | 
| 
 
			 | 
organization or the performance of the organization's activities. | 
| 
 
			 | 
       (d)  Not more than five percent of the money awarded under  | 
| 
 
			 | 
this subchapter may be used for facility purchase, construction,  | 
| 
 
			 | 
remodel, or renovation purposes during any year.  Expenditures of  | 
| 
 
			 | 
money awarded under this subchapter for facility purchase,  | 
| 
 
			 | 
construction, remodel, or renovation projects must benefit cancer  | 
| 
 
			 | 
prevention and research. | 
| 
 
			 | 
       SECTION 11.  Section 102.251, Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       Sec. 102.251.  RULES FOR GRANT AWARD PROCEDURE [DUTIES OF 
 | 
| 
 
			 | 
SCIENTIFIC RESEARCH AND PREVENTION PROGRAMS COMMITTEE].  (a)  The  | 
| 
 
			 | 
oversight committee shall issue rules regarding the procedure for  | 
| 
 
			 | 
awarding grants to an applicant under this chapter.  The rules must  | 
| 
 
			 | 
include the following procedures: | 
| 
 
			 | 
             (1)  a [The] research and prevention programs committee  | 
| 
 
			 | 
shall review grant applications and make recommendations to the  | 
| 
 
			 | 
executive director [oversight committee] regarding the award of  | 
| 
 
			 | 
cancer research grants, including a prioritized list that ranks the  | 
| 
 
			 | 
grant applications in the order the committee determines  | 
| 
 
			 | 
applications should be funded; and | 
| 
 
			 | 
             (2)  the executive director shall submit to the  | 
| 
 
			 | 
oversight committee a list of grant applications that is  | 
| 
 
			 | 
substantially based on the list submitted by the committee under  | 
| 
 
			 | 
Subdivision (1) and, to the extent possible, gives[, therapy 
 | 
| 
 
			 | 
development, and clinical trial grants.
 | 
| 
 
			 | 
       [(b)
 
 
The ex officio members of the research and prevention 
 | 
| 
 
			 | 
programs committee may participate in the review and discussion of 
 | 
| 
 
			 | 
grant applications but may not vote on recommendations to the 
 | 
| 
 
			 | 
oversight committee.  In making recommendations to the oversight 
 | 
| 
 
			 | 
committee, the research and prevention programs committee shall 
 | 
| 
 
			 | 
give] priority to proposals that: | 
| 
 
			 | 
                   (A) [(1)]  could lead to immediate or long-term  | 
| 
 
			 | 
medical and scientific breakthroughs in the area of cancer  | 
| 
 
			 | 
prevention or cures for cancer; | 
| 
 
			 | 
                   (B) [(2)]  strengthen and enhance fundamental  | 
| 
 
			 | 
science in cancer research; | 
| 
 
			 | 
                   (C) [(3)]  ensure a comprehensive coordinated  | 
| 
 
			 | 
approach to cancer research; | 
| 
 
			 | 
                   (D) [(4)]  are interdisciplinary or  | 
| 
 
			 | 
interinstitutional; | 
| 
 
			 | 
                   (E) [(5)]  address federal or other major  | 
| 
 
			 | 
research sponsors' priorities in emerging scientific or technology  | 
| 
 
			 | 
fields in the area of cancer prevention or cures for cancer; | 
| 
 
			 | 
                   (F) [(6)]  are matched with funds available by a  | 
| 
 
			 | 
private or nonprofit entity and institution or institutions of  | 
| 
 
			 | 
higher education; | 
| 
 
			 | 
                   (G) [(7)]  are collaborative between any  | 
| 
 
			 | 
combination of private and nonprofit entities, public or private  | 
| 
 
			 | 
agencies or institutions in this state, and public or private  | 
| 
 
			 | 
institutions outside this state; | 
| 
 
			 | 
                   (H) [(8)]  have a demonstrable economic  | 
| 
 
			 | 
development benefit to this state; | 
| 
 
			 | 
                   (I) [(9)]  enhance research superiority at  | 
| 
 
			 | 
institutions of higher education in this state by creating new  | 
| 
 
			 | 
research superiority, attracting existing research superiority  | 
| 
 
			 | 
from institutions not located in this state and other research  | 
| 
 
			 | 
entities, or enhancing existing research superiority by attracting  | 
| 
 
			 | 
from outside this state additional researchers and resources; and | 
| 
 
			 | 
                   (J) [(10)]  expedite innovation and  | 
| 
 
			 | 
commercialization, attract, create, or expand private sector  | 
| 
 
			 | 
entities that will drive a substantial increase in high-quality  | 
| 
 
			 | 
jobs, and increase higher education applied science or technology  | 
| 
 
			 | 
research capabilities. | 
| 
 
			 | 
       (b) [(c)]  A member of a [the] research and prevention  | 
| 
 
			 | 
programs committee may not attempt to use the committee member's  | 
| 
 
			 | 
official position to influence a decision to approve or award a  | 
| 
 
			 | 
grant or contract to the committee member's employer. | 
| 
 
			 | 
       SECTION 12.  Section 102.252, Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       Sec. 102.252.  OVERRIDING [RESEARCH AND PREVENTION PROGRAMS 
 | 
| 
 
			 | 
COMMITTEE] RECOMMENDATIONS.  The oversight committee must follow  | 
| 
 
			 | 
the funding recommendations of the executive director in the order  | 
| 
 
			 | 
the executive director submits the applications to the oversight  | 
| 
 
			 | 
committee [research and prevention programs committee] unless  | 
| 
 
			 | 
two-thirds of the members of the oversight committee vote to  | 
| 
 
			 | 
disregard a recommendation. | 
| 
 
			 | 
       SECTION 13.  Section 102.255(d), Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       (d)  Before the oversight committee may make for cancer  | 
| 
 
			 | 
research any grant of any proceeds of the bonds issued under  | 
| 
 
			 | 
Subchapter E, the recipient of the grant must have an amount of  | 
| 
 
			 | 
funds equal to one-half of the grant dedicated to the research that  | 
| 
 
			 | 
is the subject of the grant request. | 
| 
 
			 | 
       SECTION 14.  Section 102.260, Health and Safety Code, is  | 
| 
 
			 | 
amended to read as follows: | 
| 
 
			 | 
       Sec. 102.260.  GRANT EVALUATION [PEER REVIEW].  (a)  The  | 
| 
 
			 | 
oversight  [research  and prevention programs] committee shall  | 
| 
 
			 | 
require as a condition of a grant that the [a peer review progress 
 | 
| 
 
			 | 
oversight review of each] grant recipient submit to regular  | 
| 
 
			 | 
inspection reviews of the grant project by institute staff,  | 
| 
 
			 | 
including progress oversight reviews, to ensure compliance with the  | 
| 
 
			 | 
terms of the award and to ensure the scientific merit of the  | 
| 
 
			 | 
research[.
 
 
The research
 
 
and prevention programs committee shall 
 | 
| 
 
			 | 
report to the oversight committee any recommendations for 
 | 
| 
 
			 | 
subsequent actions]. | 
| 
 
			 | 
       (b)  The executive director shall determine the grant review  | 
| 
 
			 | 
process under this section.  The executive director may terminate  | 
| 
 
			 | 
grants that do not meet contractual obligations. | 
| 
 
			 | 
       (c)  The executive director shall report at least annually to  | 
| 
 
			 | 
the oversight committee on the progress and continued merit of each  | 
| 
 
			 | 
research program funded by the institute. | 
| 
 
			 | 
       SECTION 15.  Subchapter F, Chapter 102, Health and Safety  | 
| 
 
			 | 
Code, is amended by adding Section 102.262 to read as follows: | 
| 
 
			 | 
       Sec. 102.262.  PUBLIC INFORMATION.  The following  | 
| 
 
			 | 
information is public information and may be disclosed under  | 
| 
 
			 | 
Chapter 552, Government Code: | 
| 
 
			 | 
             (1)  the applicant's name and address; | 
| 
 
			 | 
             (2)  the amount of funding applied for; | 
| 
 
			 | 
             (3)  the type of cancer to be addressed under the  | 
| 
 
			 | 
proposal; and | 
| 
 
			 | 
             (4)  any other information designated by the institute  | 
| 
 
			 | 
with the consent of the grant applicant. | 
| 
 
			 | 
       SECTION 16.  Sections 102.151(a) and (c), Health and Safety  | 
| 
 
			 | 
Code, are repealed. | 
| 
 
			 | 
       SECTION 17.  Not later than December 1, 2009, the governor,  | 
| 
 
			 | 
lieutenant governor, and speaker of the house of representatives  | 
| 
 
			 | 
each shall designate one member of the Cancer Prevention and  | 
| 
 
			 | 
Research Institute of Texas Oversight Committee appointed by that  | 
| 
 
			 | 
person to serve a term expiring January 31, 2011, one member  | 
| 
 
			 | 
appointed by that person to serve a term expiring January 31, 2013,  | 
| 
 
			 | 
and one member appointed by that person to serve a term expiring  | 
| 
 
			 | 
January 31, 2015. | 
| 
 
			 | 
       SECTION 18.  This Act takes effect immediately if it  | 
| 
 
			 | 
receives a vote of two-thirds of all the members elected to each  | 
| 
 
			 | 
house, as provided by Section 39, Article III, Texas Constitution.   | 
| 
 
			 | 
If this Act does not receive the vote necessary for immediate  | 
| 
 
			 | 
effect, this Act takes effect September 1, 2009. | 
|   | 
|   | 
|   | 
______________________________ | 
______________________________ | 
|   | 
   President of the Senate | 
Speaker of the House      | 
|   | 
|   | 
| 
 		
			 | 
       I certify that H.B. No. 1358 was passed by the House on May 7,  | 
| 
 		
			 | 
2009, by the following vote:  Yeas 141, Nays 2, 1 present, not  | 
| 
 		
			 | 
voting. | 
| 
 		
			 | 
 | 
| 
 		
			 | 
______________________________ | 
| 
 		
			 | 
Chief Clerk of the House    | 
|   | 
|   | 
| 
 		
			 | 
       I certify that H.B. No. 1358 was passed by the Senate on May  | 
| 
 		
			 | 
21, 2009, by the following vote:  Yeas 30, Nays 0. | 
| 
 		
			 | 
 | 
| 
 		
			 | 
______________________________ | 
| 
 		
			 | 
Secretary of the Senate     | 
| 
 		
			 | 
APPROVED:  _____________________ | 
| 
 		
			 | 
                   Date           | 
| 
 		
			 | 
  | 
| 
 		
			 | 
          _____________________ | 
| 
 		
			 | 
                 Governor        |